全文获取类型
收费全文 | 47065篇 |
免费 | 3771篇 |
国内免费 | 111篇 |
专业分类
耳鼻咽喉 | 375篇 |
儿科学 | 1904篇 |
妇产科学 | 1293篇 |
基础医学 | 6748篇 |
口腔科学 | 972篇 |
临床医学 | 6480篇 |
内科学 | 9132篇 |
皮肤病学 | 907篇 |
神经病学 | 4801篇 |
特种医学 | 1074篇 |
外科学 | 4105篇 |
综合类 | 406篇 |
一般理论 | 62篇 |
预防医学 | 5758篇 |
眼科学 | 671篇 |
药学 | 2638篇 |
2篇 | |
中国医学 | 54篇 |
肿瘤学 | 3565篇 |
出版年
2024年 | 60篇 |
2023年 | 422篇 |
2022年 | 582篇 |
2021年 | 1263篇 |
2020年 | 939篇 |
2019年 | 1396篇 |
2018年 | 1531篇 |
2017年 | 1203篇 |
2016年 | 1329篇 |
2015年 | 1398篇 |
2014年 | 1783篇 |
2013年 | 2619篇 |
2012年 | 3653篇 |
2011年 | 3769篇 |
2010年 | 2066篇 |
2009年 | 1832篇 |
2008年 | 3048篇 |
2007年 | 3134篇 |
2006年 | 3079篇 |
2005年 | 2898篇 |
2004年 | 2808篇 |
2003年 | 2575篇 |
2002年 | 2317篇 |
2001年 | 362篇 |
2000年 | 265篇 |
1999年 | 315篇 |
1998年 | 524篇 |
1997年 | 391篇 |
1996年 | 348篇 |
1995年 | 339篇 |
1994年 | 267篇 |
1993年 | 266篇 |
1992年 | 184篇 |
1991年 | 158篇 |
1990年 | 144篇 |
1989年 | 111篇 |
1988年 | 123篇 |
1987年 | 87篇 |
1986年 | 93篇 |
1985年 | 97篇 |
1984年 | 100篇 |
1983年 | 100篇 |
1982年 | 127篇 |
1981年 | 123篇 |
1980年 | 103篇 |
1979年 | 62篇 |
1978年 | 66篇 |
1977年 | 49篇 |
1976年 | 45篇 |
1972年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
The association between family affluence and smoking among 15‐year‐old adolescents in 33 European countries,Israel and Canada: the role of national wealth 下载免费PDF全文
13.
14.
Gregers Mads Christian Tofte Mikkelsen Søren Lindvig Katrine Prier Brøchner Anne Craveiro 《Neurocritical care》2020,33(1):273-282
Neurocritical Care - For years, the use of ketamine as an anesthetic to patients suffering from acute brain injury has been debated because of its possible deleterious effects on the cerebral... 相似文献
15.
16.
17.
18.
Bob C. Mulder Merel A. A. van Lelyveld Sigrid C. J. M. Vervoort Anne Marike Lokhorst Cees M. J. van Woerkum Jan M. Prins 《Health communication》2016,31(1):35-46
Since the introduction of cART (combination antiretroviral therapy), HIV has evolved into a chronic disease such that it requires lifelong medical treatment to which patients must adhere. Communication with health care providers is pivotal in supporting patients to adapt to having HIV and adhering to treatment, in order to maintain health and quality of life. Previous research indicates that communication is optimal when it matches patient preferences for information exchange, relationship establishment, and involvement in treatment decisions. The aim of the present study is to explore HIV patient communication preferences as well as patient experiences with their providers (not) matching their preferences. A second aim is to explore provider beliefs about patient preferences and provider views on optimal communication. Data were collected through interviews with 28 patients and 11 providers from two academic hospitals. Results indicate that patient preferences reflect their cognitive, emotional, and practical needs such that patients look to increase their sense of control over their HIV. Patients aim to further increase their sense of control (by proxy) through their relationship with their providers and through their decisional involvement preferences. Providers are well aware of patient communication preferences but do not explicate underlying control needs. Implications for clinical practice are discussed. 相似文献
19.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.20.
Renaud Snanoudj Nassim Kamar Elisabeth Cassuto Sophie Caillard Marie Metzger Pierre Merville Antoine Thierry Isabelle Jollet Philippe Grimbert Dany Anglicheau Marc Hazzan Gabriel Choukroun Bruno Hurault De Ligny Bénedicte Janbon Vincent Vuiblet Anne Devys Yann Le Meur Michel Delahousse Jean-Luc Taupin 《Kidney international》2019,95(6):1471-1485